AI-Driven Drug Discovery Platform Development

Integrate generative AI for de novo molecule design with molecular simulation to rapidly generate and prioritize high-quality candidates, compressing discovery cycles from months to weeks.

Deploy custom-trained models on proprietary assay data to improve binding affinity and ADMET property predictions, reducing costly late-stage attrition by focusing resources on the most promising candidates.

Engineer robust MLOps pipelines for heterogeneous biological data (omics, HTS, literature), ensuring data integrity, reproducibility, and seamless integration with existing lab informatics systems. Learn about our approach to Bio-AI Data Pipeline and MLOps Engineering.

Build with compliance by design. Our platforms include embedded tracking for data lineage, model versioning, and performance validation, creating the documentation foundation required for FDA/EMA submissions.

Shift experimental focus from low-probability screening to high-confidence validation. AI-driven triage reduces wet-lab resource consumption on poor candidates, directly lowering operational costs.

Orchestrate specialized AI agents for target analysis, literature mining, and synthetic route planning into a cohesive discovery workflow, automating complex, multi-step research tasks. Explore our capabilities in Agentic Workflow Design and Integration.

We conduct a deep-dive technical assessment of your target pipeline, existing data assets, and scientific objectives. We define the optimal AI architecture—selecting between generative models, GNNs, or fine-tuned foundation models like ESM—and establish success metrics tied to wet-lab validation.

Learn more about our strategic approach in our Bio-AI Foundation Model Consulting service.

We build robust, scalable MLOps pipelines to ingest, featurize, and manage your heterogeneous biological data (omics, HTS, literature). This includes implementing synthetic data generation where needed and ensuring full data lineage for regulatory compliance.

This phase is critical for success, as detailed in our Bio-AI Data Pipeline and MLOps Engineering offering.

Our team develops and integrates the core AI models—customizing generative algorithms for molecular design, fine-tuning structure prediction models like AlphaFold for your targets, or implementing GNNs for pathway analysis. We prioritize explainability and integration with existing scientific software.

We engineer the full-stack application that unifies data, models, and simulation tools into a cohesive platform for your scientists. This includes intuitive interfaces for experiment design, result visualization, and collaborative analysis, built with security and scalability as first principles.

We rigorously validate model predictions against internal or public benchmarks and design pilot wet-lab experiments. The platform is then deployed into your secure cloud or on-premises environment with full monitoring, logging, and model retraining pipelines activated.

Ensuring regulatory readiness is key, as outlined in our Bio-AI Regulatory Compliance and Validation service.

We provide ongoing support to iteratively improve the platform based on new data and experimental feedback. This includes model retraining, feature expansion, and performance tuning to ensure the platform evolves as a core competitive asset in your R&D lifecycle.